• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导化疗后延迟开始放疗的影响:III 期非小细胞肺癌的加速再增殖。

Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.

机构信息

Department of Radiation Oncology, School of Medicine, University of California, San Francisco, California 94115, USA.

出版信息

J Thorac Oncol. 2011 Nov;6(11):1857-64. doi: 10.1097/JTO.0b013e318229a41e.

DOI:10.1097/JTO.0b013e318229a41e
PMID:21964528
Abstract

INTRODUCTION

For patients with stage III non-small cell lung cancer treated with induction chemotherapy (ICT), delayed initiation of subsequent radiotherapy (RT) may allow for repopulation in the interval between treatment modalities and during the early phase of RT. We quantified the impact of postinduction RT timing by evaluating the pace of tumor regrowth.

METHODS

Institutionally approved retrospective review identified 21 analyzable patients with stage III non-small cell lung cancer who had platinum-based ICT followed by RT+/- chemotherapy from 2002 to 2009. Radiographic response was determined by RECIST criteria and the volume of the single largest tumor mass on the pre-ICT, post-ICT, and RT-planning computed tomography scans.

RESULTS

After ICT, the median percent volume change from pre-ICT baseline was -41% (range -86 to +86%). By the RT-planning computed tomography scan, the median percent volume change from the post-ICT timepoint was +40% (range -11 to +311%) and the median volume change was +20 ml (range -4 to 102 ml); these changes were significant (p = 0.0002). Similar results were seen for tumor diameter. A correlation was observed between the amount of delay and degree of regrowth for percent volume (p = 0.0006) and percent diameter change (p = 0.003). A delay greater than 21 days produced greater increases in percent volume change (p = 0.002) and percent diameter (p = 0.055) than lesser delays.

CONCLUSIONS

After ICT, tumor regrowth can occur within a few weeks. Radiation treatment planning should begin as soon as possible after the administration of ICT to maximize the benefits of cytoreduction.

摘要

简介

对于接受诱导化疗(ICT)治疗的 III 期非小细胞肺癌患者,随后延迟开始放疗(RT)可能会允许在治疗方式之间的间隔期间和 RT 的早期阶段发生细胞再增殖。我们通过评估肿瘤再生长的速度来量化诱导后 RT 时间的影响。

方法

机构批准的回顾性研究确定了 21 名可分析的 III 期非小细胞肺癌患者,他们在 2002 年至 2009 年间接受了基于铂类的 ICT 治疗,随后进行了 RT+/-化疗。通过 RECIST 标准和 ICT 前、ICT 后和 RT 计划 CT 扫描上的单个最大肿瘤质量的体积来确定放射学反应。

结果

在 ICT 之后,从 ICT 基线的中位数百分比体积变化为 -41%(范围 -86 至 +86%)。在 RT 计划 CT 扫描时,从 ICT 时间点的中位数百分比体积变化为 +40%(范围 -11 至 +311%),中位数体积变化为+20 ml(范围 -4 至 102 ml);这些变化具有统计学意义(p = 0.0002)。对于肿瘤直径也观察到类似的结果。观察到延迟量与体积百分比变化(p = 0.0006)和直径百分比变化(p = 0.003)之间存在相关性。延迟时间大于 21 天会导致体积百分比变化(p = 0.002)和直径百分比(p = 0.055)的增加更大。

结论

在 ICT 之后,肿瘤可能在几周内发生再生长。为了最大限度地发挥细胞减灭的益处,应在 ICT 给药后尽快开始进行放射治疗计划。

相似文献

1
Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.诱导化疗后延迟开始放疗的影响:III 期非小细胞肺癌的加速再增殖。
J Thorac Oncol. 2011 Nov;6(11):1857-64. doi: 10.1097/JTO.0b013e318229a41e.
2
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.一项针对IIIA期和IIIB期非小细胞肺癌的II期多中心试验,采用卡铂和吉西他滨诱导化疗,随后进行放疗,同时联合低剂量紫杉醇和吉西他滨。
J Thorac Oncol. 2007 Oct;2(10):927-32. doi: 10.1097/JTO.0b013e3181560b92.
3
Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).一项针对局部晚期不可切除非小细胞肺癌(NSCLC)采用新型三联诱导化疗方案(PACCAGE)随后进行巩固放疗的研究的最终总体结果。
J Thorac Oncol. 2009 Jun;4(6):728-35. doi: 10.1097/JTO.0b013e3181a4ec14.
4
The impact of induction chemotherapy on the dosimetric parameters of subsequent radiotherapy: an investigation of 30 consecutive patients with locally-advanced non-small cell lung cancer and modern radiation planning techniques.诱导化疗对后续放疗剂量学参数的影响:对30例连续的局部晚期非小细胞肺癌患者及现代放射治疗计划技术的研究。
Radiat Oncol. 2015 Jan 31;10:32. doi: 10.1186/s13014-015-0332-9.
5
Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.不能手术的 III 期非小细胞肺癌患者采用吉西他滨和顺铂诱导化疗,随后行适形放疗至 74 Gy,同时每周给予紫杉醇和顺铂治疗的 II 期临床试验。
J Thorac Oncol. 2011 Mar;6(3):553-8. doi: 10.1097/JTO.0b013e31820b8d88.
6
[Induction chemotherapy followed by concomitant combined radiotherapy and chemotherapy in stage III non-small cell bronchial carcinoma].[III期非小细胞支气管癌的诱导化疗后同步放化疗]
Cancer Radiother. 1997;1(2):121-31. doi: 10.1016/s1278-3218(97)83528-7.
7
Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.III 期非小细胞肺癌的多模态治疗:术前顺铂和吉西他滨联合放疗的 II 期试验分析。
J Thorac Oncol. 2009 Dec;4(12):1517-23. doi: 10.1097/JTO.0b013e3181b9e860.
8
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).一项关于紫杉醇、卡铂和超分割放射治疗局部晚期不可切除非小细胞肺癌的II期研究(范德比尔特癌症中心附属网络研究)
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):931-7. doi: 10.1016/s0360-3016(00)00420-x.
9
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.诱导顺铂/长春碱与放疗联合应用对比单纯放疗治疗不可切除的肺鳞状细胞癌:RTOG 88-08/ECOG 4588中按细胞类型划分的失败模式。放射治疗肿瘤学组。东部肿瘤协作组。
Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):537-44. doi: 10.1016/s0360-3016(97)00365-9.
10
A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.一项回顾性研究:含铂类的诱导化疗联合吉西他滨或紫杉醇治疗 IIB-IIIA 期中央型非小细胞肺癌。
World J Surg Oncol. 2013 Mar 21;11:76. doi: 10.1186/1477-7819-11-76.

引用本文的文献

1
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution.休眠、干性和治疗抵抗:癌症进化中的相互关联的参与者。
Cancer Metastasis Rev. 2023 Mar;42(1):197-215. doi: 10.1007/s10555-023-10092-4. Epub 2023 Feb 9.
2
CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer.CRIPTO是化疗诱导的非小细胞肺癌干细胞扩增的标志物。
Front Oncol. 2022 Jun 2;12:830873. doi: 10.3389/fonc.2022.830873. eCollection 2022.
3
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question.
非小细胞肺癌的术前和术后放疗:仍是一个悬而未决的问题。
Transl Lung Cancer Res. 2021 Apr;10(4):1950-1959. doi: 10.21037/tlcr-20-472.
4
Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.局限期小细胞肺癌患者的胸部放疗时间比剂量强化更重要:两项前瞻性研究的平行比较。
Strahlenther Onkol. 2020 Feb;196(2):172-181. doi: 10.1007/s00066-019-01539-1. Epub 2019 Nov 29.
5
Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.胸部放疗时机和时间对局限期小细胞肺癌无进展生存期的影响。
Cancer Med. 2018 Sep;7(9):4208-4216. doi: 10.1002/cam4.1616. Epub 2018 Jul 17.
6
Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model.基于生物数学模型预测非小细胞肺癌患者联合化疗和放疗的治疗反应。
Sci Rep. 2017 Oct 19;7(1):13542. doi: 10.1038/s41598-017-13646-z.
7
Improving efficacy and efficiency through the implementation of a new organisational model in a Radiation Oncology Department.通过在放射肿瘤学部门实施新的组织模型来提高疗效和效率。
Clin Transl Oncol. 2017 Nov;19(11):1375-1381. doi: 10.1007/s12094-017-1678-2. Epub 2017 May 29.
8
Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach.非小细胞肺癌术后放疗与辅助化疗的序贯:基于非循证方法的未决问题
J Thorac Dis. 2016 Jul;8(7):1381-5. doi: 10.21037/jtd.2016.05.76.
9
The Role of Translational Regulation in Survival after Radiation Damage; an Opportunity for Proteomics Analysis.翻译调控在辐射损伤后存活中的作用;蛋白质组学分析的契机。
Proteomes. 2014 Jun;2(2):272-290. doi: 10.3390/proteomes2020272.
10
Clinical efficacy of CyberKnife combined with chemotherapy and hyperthermia for advanced non-small cell lung cancer.射波刀联合化疗及热疗治疗晚期非小细胞肺癌的临床疗效
Mol Clin Oncol. 2013 May;1(3):527-530. doi: 10.3892/mco.2013.95. Epub 2013 Mar 19.